Article info

Download PDFPDF

OWE-05 Interim long-term safety/efficacy of risankizumab treatment in crohn’s disease patients from the open-label extension study
Free

Authors

Citation

Ferrante M, Panes J, Baert F, et al
OWE-05 Interim long-term safety/efficacy of risankizumab treatment in crohn’s disease patients from the open-label extension study

Publication history

  • First published June 1, 2019.
Online issue publication 
June 16, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.